Skip to main content

ERIS Lifesciences Ltd

NSE: ERIS BSE: 540596Pharma

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]

1,338
52W: ₹1200 — ₹1910
PE 62.4 · Book ₹203 · +559% vs book
Market Cap₹18,539 Cr
Stock P/E62.4Price to Earnings
ROCE6.86%Return on Capital
ROE3.02%Return on Equity
Div. Yield0.55%Face Value ₹1

Weaknesses

  • Stock is trading at 6.56 times its book value
  • Promoter holding has decreased over last quarter: -0.93%
  • The company has delivered a poor sales growth of 10.7% over past five years.
  • Company has a low return on equity of 11.0% over last 3 years.

Shareholding Pattern

Promoters53.92%
FIIs6.39%
DIIs20.35%
Public19.33%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters54.88%54.87%0.054.86%0.054.85%0.054.83%0.054.85%0.054.85%53.92%0.9
FIIs14.59%8.01%6.68.36%0.38.43%0.18.39%0.07.21%1.26.85%0.46.39%0.5
DIIs16.23%18.64%2.418.07%0.618.07%18.18%0.119.36%1.220.31%0.920.35%0.0
Public14.3%18.47%4.218.73%0.318.64%0.118.59%0.118.57%0.017.97%0.619.33%1.4

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales409.71324.41341.3456.69436.56399.73404.77578.64650.5315.29
Expenses265.22249.98261.91333.31293.93300.16283.8362.32353.62237.94
Operating Profit144.4974.4379.39123.38142.6399.57120.97216.32296.8877.35
OPM %35.27%22.94%23.26%27.02%32.67%24.91%29.89%37.38%45.64%24.53%
Net Profit117.8131.6539.5117.0428.11.7830.4799.99149.573.09
EPS ₹8.662.332.91.252.060.132.247.3410.980.23

AI Insights

Revenue Trend

TTM revenue at ₹1,949Cr, up 14.8% YoY. OPM at 36%.

Debt Position

Borrowings at ₹2,189Cr. Debt-to-equity ratio: 0.79x. Moderate leverage.

Institutional Flow

DIIs: 20.35% (+9.62pp change). FIIs: 6.39% (-7.39pp change). Promoters hold 53.92%.

Margin & Efficiency

ROCE declining from 56% (Mar 2014) to 7% (Mar 2025). Working capital days: -99.

Valuation

PE 62.4x with 6.86% ROCE. Price is 559% above book value of ₹203. Dividend yield: 0.55%.

Recent Announcements